Evidence map›Paper›PMID 35347434›Full record

ArticleCellular and molecular life sciences : CMLS2022

Essential role of a conserved aspartate for the enzymatic activity of plasmanylethanolamine desaturase.

Ernst R Werner, Monica L Fernández-Quintero, Nicolas Hulo, Georg Golderer, Sabrina Sailer, Katharina Lackner, Gabriele Werner-Felmayer, Klaus R Liedl, Katrin Watschinger

Open access · hybridAbstract read
In one paragraph

Article in Cellular and molecular life sciences : CMLS, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. HAP1, a new revolutionary cell model for gene editing using CRISPR-Cas9.Frontiers in cell and developmental biology · 2023
    Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Ernst R WernerInstitute of Biological Chemistry, Biocenter, Medical University of Innsbruck, Innrain 80-82, 6020, Innsbruck, Austria.ORCID http://orcid.org/0000-0003-1948-3391
Monica L Fernández-QuinteroDepartment of General, Inorganic and Theoretical Chemistry, University of Innsbruck, Innrain 80-82, 6020, Innsbruck, Austria.ORCID http://orcid.org/0000-0002-6811-6283
Nicolas HuloInstitute of Genetics and Genomics of Geneva, University of Geneva, 1, rue Michel Servet, 1211, Geneva 4, Switzerland.
Georg GoldererInstitute of Biological Chemistry, Biocenter, Medical University of Innsbruck, Innrain 80-82, 6020, Innsbruck, Austria.
Sabrina SailerInstitute of Biological Chemistry, Biocenter, Medical University of Innsbruck, Innrain 80-82, 6020, Innsbruck, Austria.ORCID http://orcid.org/0000-0002-6375-5393
Katharina LacknerInstitute of Biological Chemistry, Biocenter, Medical University of Innsbruck, Innrain 80-82, 6020, Innsbruck, Austria.ORCID http://orcid.org/0000-0003-3260-9139
Gabriele Werner-FelmayerInstitute of Biological Chemistry, Biocenter, Medical University of Innsbruck, Innrain 80-82, 6020, Innsbruck, Austria.ORCID http://orcid.org/0000-0002-2340-8063
Klaus R LiedlDepartment of General, Inorganic and Theoretical Chemistry, University of Innsbruck, Innrain 80-82, 6020, Innsbruck, Austria.ORCID http://orcid.org/0000-0002-0985-2299
Katrin WatschingerInstitute of Biological Chemistry, Biocenter, Medical University of Innsbruck, Innrain 80-82, 6020, Innsbruck, Austria. katrin.watschinger@i-med.ac.at.ORCID http://orcid.org/0000-0002-1122-8444
Innsbruck Medical University · ATUniversität Innsbruck · ATUniversity of Geneva · CH

Funding

Austrian Science Fund P29551Austrian Science Fund P30800Austrian Science Fund P34723Austrian Science Fund FWF P 29551Austrian Science Fund FWF P 30800Austrian Science Fund FWF P 34518Austrian Science Fund FWF P 34723
6 · The paper itself

Abstract

Plasmalogens are an abundant class of glycerophospholipids in the mammalian body, with special occurrence in the brain and in immune cell membranes. Plasmanylethanolamine desaturase (PEDS1) is the final enzyme of plasmalogen biosynthesis, which introduces the characteristic 1-O-alk-1'-enyl double bond. The recent sequence identification of PEDS1 as transmembrane protein 189 showed that its protein sequence is related to a special class of plant desaturases (FAD4), with whom it shares a motif of 8 conserved histidines, which are essential for the enzymatic activity. In the present work, we wanted to gain more insight into the sequence-function relationship of this enzyme and mutated to alanine additional 28 amino acid residues of murine plasmanylethanolamine desaturase including those 20 residues, which are also totally conserved-in addition to the eight-histidine-motif-among the animal PEDS1 and plant FAD4 plant desaturases. We measured the enzymatic activity by transient transfection of tagged murine PEDS1 expression clones to a PEDS1-deficient human HAP1 cell line by monitoring of labeled plasmalogens formed from supplemented 1-O-pyrenedecyl-sn-glycerol in relation to recombinant protein expression. Surprisingly, only a single mutation, namely aspartate 100, led to a total loss of PEDS1 activity. The second strongest impact on enzymatic activity had mutation of phenylalanine 118, leaving only 6% residual activity. A structural model obtained by homology modelling to available structures of stearoyl-CoA reductase predicted that this aspartate 100 residue interacts with histidine 96, and phenylalanine 118 interacts with histidine 187, both being essential histidines assumed to be involved in the coordination of the di-metal center of the enzyme.

Indexed as

Aspartic AcidOxidoreductasesAmino Acid SequenceAnimalsHumansMammalsMicePlantsAspartic AcidOxidoreductasesplasmanylethanolamine desaturaseDi-iron centerPlasmalogen biosynthesisPredicted structureSite-directed mutagenesis

Identifiers

PMID35347434
PMCPMC8960569
OpenAlexW4220895490

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.